AGREEMENTSchedule 13g Agreement • December 17th, 2021 • Frazier Life Sciences Public Fund, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Ordinary Shares of Autolus Therapeutics plc.
AGREEMENTAgreement • November 27th, 2024 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Savara Inc.
AGREEMENTSchedule 13g Agreement • February 9th, 2024 • Frazier Life Sciences Public Fund, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Adverum Biotechnologies, Inc.
AGREEMENTSchedule 13g Agreement • March 1st, 2022 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Cogent Biosciences, Inc.
AGREEMENTSchedule 13d Agreement • September 23rd, 2024 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need to be filed with respect to the ownership by each of the undersigned of shares of Common Stock of MBX Biosciences, Inc.
AGREEMENTSchedule 13g Agreement • May 16th, 2022 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Tricida, Inc.
AGREEMENTSchedule 13g Agreement • February 13th, 2024 • Frazier Life Sciences Public Fund, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Gritstone bio, Inc.
AGREEMENTSchedule 13g Agreement • September 12th, 2022 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Allakos Inc.
AGREEMENTSchedule 13g Agreement • July 15th, 2024 • Frazier Life Sciences Public Fund, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Elevation Oncology, Inc.
AGREEMENTSchedule 13g Agreement • February 13th, 2024 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Theseus Pharmaceuticals, Inc.
AGREEMENTSchedule 13g Agreement • February 14th, 2023 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Syndax Pharmaceuticals, Inc.
AGREEMENTAgreement • January 23rd, 2023 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Theseus Pharmaceuticals, Inc.
AGREEMENTSchedule 13g Agreement • January 25th, 2024 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of ORIC Pharmaceuticals, Inc.
AGREEMENTExhibit Agreement • December 30th, 2022 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need to be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Kalvista Pharmaceuticals, Inc.
AGREEMENTSchedule 13g Agreement • February 14th, 2023 • Frazier Life Sciences Public Fund, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Gritstone bio, Inc.
AGREEMENTSchedule 13g Agreement • April 18th, 2022 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Trevi Therapeutics, Inc.
AGREEMENTSchedule 13g Agreement • November 5th, 2024 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Eledon Pharmaceuticals, Inc.
AGREEMENTSchedule 13g Agreement • November 6th, 2024 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Trevi Therapeutics, Inc.
AGREEMENTSchedule 13g Agreement • March 29th, 2024 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Puma Biotechnology, Inc.
AGREEMENTSchedule 13g Agreement • September 21st, 2021 • Frazier Life Sciences Public Fund, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Gritstone bio, Inc.
AGREEMENTSchedule 13g Agreement • April 10th, 2024 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of AN2 Therapeutics, Inc.
AGREEMENTSchedule 13g Agreement • August 26th, 2021 • Frazier Life Sciences Public Fund, L.P. • Services-medical laboratories
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Viridian Therapeutics, Inc.
AGREEMENTSchedule 13g Agreement • May 6th, 2024 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of AnaptysBio, Inc.
JOINT FILING agreementJoint Filing Agreement • December 30th, 2021 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.
AGREEMENTAgreement • May 31st, 2024 • Frazier Life Sciences Public Fund, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need to be filed with respect to the ownership by each of the undersigned of shares of Common Stock of HilleVax, Inc.
AGREEMENTSchedule 13g Agreement • April 9th, 2024 • Frazier Life Sciences Public Fund, L.P. • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Elevation Oncology, Inc.
AGREEMENTSchedule 13g Agreement • August 16th, 2021 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Sierra Oncology, Inc.
AGREEMENTSchedule 13g Agreement • May 29th, 2024 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Erasca, Inc.
AGREEMENTSchedule 13g Agreement • January 28th, 2022 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Pardes Biosciences, Inc. (f/k/a FS Development Corp. II).
AGREEMENTSchedule 13g Agreement • October 5th, 2023 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Syndax Pharmaceuticals, Inc.
AGREEMENTSchedule 13g Agreement • March 17th, 2022 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Ordinary Shares of Gracell Biotechnologies Inc.
AGREEMENTSchedule 13g Agreement • June 25th, 2024 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Disc Medicine, Inc.
AGREEMENTSchedule 13g Agreement • February 14th, 2023 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Cogent Biosciences, Inc.
AGREEMENTExhibit Agreement • May 26th, 2023 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of Common Stock of Phathom Pharmaceuticals, Inc.
